Holly Fontenot to Uterine Cervical Neoplasms
This is a "connection" page, showing publications Holly Fontenot has written about Uterine Cervical Neoplasms.
Connection Strength
4.292
-
Heys D, Liebermann E, Fontenot HB. In-Clinic Self-swab for Human Papillomavirus Offers New Option for Cervical Cancer Screening. Nurs Womens Health. 2025 Aug; 29(4):264-268.
Score: 0.676
-
Fontenot HB, Fuzzell L, Brownstein NC, Lake P, Michel A, Vadaparampil ST, Perkins RB. Health Care Provider Willingness to Recommend Self-collected Tests for Human Papillomavirus: A Mixed Methods Examination of Associated Factors. Womens Health Issues. 2024 Sep-Oct; 34(5):506-517.
Score: 0.633
-
Bustamante G, Liebermann E, McNair K, Fontenot HB. Women's perceptions and preferences for cervical cancer screening in light of updated guidelines. J Am Assoc Nurse Pract. 2023 Nov 01; 35(11):699-707.
Score: 0.604
-
Fontenot HB, Fantasia HC. HPV9 Vaccine for the Prevention of Human Papillomavirus-Related Cancers. Nurs Womens Health. 2015 Aug-Sep; 19(4):365-70.
Score: 0.341
-
Fontenot HB. Urine-based HPV testing as a method to screen for cervical cancer. Nurs Womens Health. 2015 Feb-Mar; 19(1):59-65.
Score: 0.330
-
Fontenot HB, Morelock N. HPV in men is a women's health issue. Nurs Womens Health. 2012 Feb-Mar; 16(1):57-65.
Score: 0.268
-
Olson A, Fuzzell L, Brownstein NC, Fontenot HB, Michel A, Lake P, Vadaparampil ST, Perkins RB. Factors Associated With Guideline-Concordant Cervical Cancer Screening Exit: A Mixed Methods Study. Womens Health Issues. 2025 Nov-Dec; 35(6):415-423.
Score: 0.172
-
Fuzzell L, Brownstein NC, Fontenot HB, Lake P, Michel A, Perkins RB, Vadaparampil ST. Clinician Characteristics Associated With Adoption of Updated National Colposcopy Guidelines. J Low Genit Tract Dis. 2025 Apr 01; 29(2):153-160.
Score: 0.165
-
Perkins RB, Fuzzell L, Brownstein NC, Fontenot HB, Michel A, Neggers M, Lake P, Vadaparampil ST. A Mixed-Methods Study Examining Guideline-Concordant Colposcopy Practices Among a National Cohort of US Colposcopists. J Low Genit Tract Dis. 2025 Apr 01; 29(2):161-167.
Score: 0.165
-
Michel AD, Fontenot HB, Fuzzell L, Brownstein NC, Lake P, Vadaparampil ST, Perkins RB. Attitudes toward the American Cancer Society's 2020 cervical cancer screening guidelines: A qualitative study of a national sample of US clinicians. Cancer. 2024 Jul 01; 130(13):2325-2338.
Score: 0.155
-
Perkins RB, Fuzzell L, Lake P, Brownstein NC, Fontenot HB, Michel A, Whitmer A, Vadaparampil ST. Factors Associated With Guideline-concordant and Excessive Cervical Cancer Screening: A Mixed Methods Study. Womens Health Issues. 2024 May-Jun; 34(3):257-267.
Score: 0.154
-
Fuzzell L, Lake P, Brownstein NC, Fontenot HB, Whitmer A, Michel A, McIntyre M, Rossi SL, Kajtezovic S, Vadaparampil ST, Perkins R. Examining the perceived impact of the COVID-19 pandemic on cervical cancer screening practices among clinicians practicing in Federally Qualified Health Centers: A mixed methods study. Elife. 2023 09 04; 12.
Score: 0.149
-
Fuzzell L, Brownstein NC, Fontenot HB, Lake PW, Michel A, Whitmer A, Rossi SL, McIntyre M, Vadaparampil ST, Perkins RB. Examining the association of clinician characteristics with perceived changes in cervical cancer screening and colposcopy practice during the COVID-19 pandemic: a mixed methods assessment. Elife. 2023 09 01; 12.
Score: 0.149
-
Liebermann E, Fontenot HB, Lim E, Matsunaga M, Zimet G, Allen JD. Preferred Location for Human Papillomavirus Self-Sampling for Cervical Cancer Screening. J Obstet Gynecol Neonatal Nurs. 2023 09; 52(5):364-373.
Score: 0.147
-
Vadaparampil ST, Fuzzell LN, Brownstein NC, Fontenot HB, Lake P, Michel A, McIntyre M, Whitmer A, Perkins RB. A cross-sectional survey examining clinician characteristics, practices, and attitudes associated with adoption of the 2019 American Society for Colposcopy and Cervical Pathology risk-based management consensus guidelines. Cancer. 2023 09 01; 129(17):2671-2684.
Score: 0.147
-
Wigle J, Fontenot HB, Zimet GD. Global Delivery of Human Papillomavirus Vaccines. Pediatr Clin North Am. 2016 Feb; 63(1):81-95.
Score: 0.022
-
Allen JD, Mohllajee AP, Shelton RC, Othus MK, Fontenot HB, Hanna R. Stage of adoption of the human papillomavirus vaccine among college women. Prev Med. 2009 May; 48(5):420-5.
Score: 0.013